Skip to content

Effect of dexmedetomidine on sleep quality after general anesthesia

Application of dexmedetomidine in improving postoperative sleep quality in patients under general anesthesia

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079610
Enrollment
Unknown
Registered
2024-01-08
Start date
2024-01-08
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sleep disorders after general anesthesia

Interventions

Control group:0.5ug/kg was used before the operation and dexmedetomidine was not used in the postoperative analgesic pump
Intervention group:0.5ug/kg was used before the operation and dexmedetomidine 1.2ug/kg/d was added to postoperative analgesia pump for 48h

Sponsors

The affiliated Suzhou hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients with general anesthesia for elective surgery (2) The patient voluntarily participated in the trial and signed the informed consent

Exclusion criteria

Exclusion criteria: (1) Presence of sick sinus syndrome, severe bradycardia (heart rate<50/min) or more than second degree atrioventricular block, permanent pacemaker implantation, severe heart failure, or ejection fraction<30% of patients (2) Patients with severe liver and kidney dysfunction (Child-Pugh B and C, CKD3-5) (3) patients with central nervous system diseases (4) Patients with sleep apnea syndrome and other types of sleep disorders (5) patients scheduled to be admitted to ICU after surgery and patients not scheduled to be admitted to ICU (6) Patients allergic to dexmedetomidine (7) Patients and their families refused to participate in the study (8) Patients with severe dementia, low cognitive function, language disorder, severe hearing or vision impairment, mental disorder, coma and other conditions that can not complete the assessment

Design outcomes

Primary

MeasureTime frame
Subjective sleep improvement ;Objective sleep improvement 48 hours after surgery ;

Secondary

MeasureTime frame
preoperative and postoperative anxiety states;delirium at 48h hours after surgery;pain score of 48h postoperatively ;nausea and vomiting;length of stay in hospital;CRP;IL-6;IL-18;IL-1ß;TNF-a;

Countries

China

Contacts

Public ContactYumin Zhu

The affiliated Suzhou hospital of Nanjing Medical University

931470338@qq.com+86 133 0620 6023

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026